Jonathan Ball
#76,300
Most Influential Person Now
British virologist
Jonathan Ball 's AcademicInfluence.com Rankings
Jonathan Ball biology Degrees
Biology
#3037
World Rank
#4702
Historical Rank
Virology
#46
World Rank
#48
Historical Rank
Download Badge
Biology
Jonathan Ball 's Degrees
- Bachelors Microbiology University of Oxford
Why Is Jonathan Ball Influential?
(Suggest an Edit or Addition)According to Wikipedia, Jonathan Kelvin Ball is professor of molecular virology at the University of Nottingham. His research relates to emerging viruses, viral vaccines and treatments, and blood-borne infections. He is also director of the Centre for Global Virus Research at the University of Nottingham.
Jonathan Ball 's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity (2020) (819)
- Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England (2021) (806)
- SARS-CoV-2 evolution during treatment of chronic infection (2021) (647)
- Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge (2008) (594)
- Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study (2021) (488)
- MAIT cells are activated during human viral infections (2016) (366)
- Monoclonal Antibody AP33 Defines a Broadly Neutralizing Epitope on the Hepatitis C Virus E2 Envelope Glycoprotein (2005) (345)
- Characterization of host‐range and cell entry properties of the major genotypes and subtypes of hepatitis C virus (2005) (295)
- Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7 (2021) (285)
- Identification of Conserved Residues in the E2 Envelope Glycoprotein of the Hepatitis C Virus That Are Critical for CD81 Binding (2006) (275)
- Human Adaptation of Ebola Virus during the West African Outbreak (2016) (176)
- Characterization of the hepatitis C virus E2 epitope defined by the broadly neutralizing monoclonal antibody AP33 (2006) (171)
- Role of Scavenger Receptor Class B Type I in Hepatitis C Virus Entry: Kinetics and Molecular Determinants (2009) (169)
- Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020 (2020) (163)
- Broadly neutralizing human monoclonal antibodies to the hepatitis C virus E2 glycoprotein (2008) (150)
- Human combinatorial libraries yield rare antibodies that broadly neutralize hepatitis C virus (2007) (149)
- Direct ex vivo comparison of the breadth and specificity of the T cells in the liver and peripheral blood of patients with chronic HCV infection (2001) (135)
- Identification of a Broadly Cross-Reacting and Neutralizing Human Monoclonal Antibody Directed against the Hepatitis C Virus E2 Protein (2007) (133)
- Neutralizing Monoclonal Antibodies against Hepatitis C Virus E2 Protein Bind Discontinuous Epitopes and Inhibit Infection at a Postattachment Step (2011) (130)
- SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway (2022) (130)
- Non-Macrophage-Tropic Human Immunodeficiency Virus Type 1 R5 Envelopes Predominate in Blood, Lymph Nodes, and Semen: Implications for Transmission and Pathogenesis (2006) (120)
- Definition of a Conserved Immunodominant Domain on Hepatitis C Virus E2 Glycoprotein by Neutralizing Human Monoclonal Antibodies (2008) (120)
- The past, present and future of neutralizing antibodies for hepatitis C virus (2014) (115)
- Development of a strand-specific RT-PCR based assay to detect the replicative form of hepatitis C virus RNA. (2001) (105)
- Genome-to-genome analysis highlights the impact of the human innate and adaptive immune systems on the hepatitis C virus (2017) (102)
- Variation in HIV-1 R5 macrophage-tropism correlates with sensitivity to reagents that block envelope: CD4 interactions but not with sensitivity to other entry inhibitors (2008) (95)
- TT virus sequence heterogeneity in vivo: evidence for co-infection with multiple genetic types. (1999) (90)
- Exponential growth, high prevalence of SARS-CoV-2, and vaccine effectiveness associated with the Delta variant (2021) (82)
- Identification of New Functional Regions in Hepatitis C Virus Envelope Glycoprotein E2 (2010) (82)
- Structural Flexibility of a Conserved Antigenic Region in Hepatitis C Virus Glycoprotein E2 Recognized by Broadly Neutralizing Antibodies (2014) (77)
- Determination of the human antibody response to the epitope defined by the hepatitis C virus-neutralizing monoclonal antibody AP33. (2007) (73)
- Hepatitis C Virus (HCV) Infection May Elicit Neutralizing Antibodies Targeting Epitopes Conserved in All Viral Genotypes (2009) (71)
- Interferon lambda 4 impacts the genetic diversity of hepatitis C virus (2019) (71)
- An alpaca nanobody inhibits hepatitis C virus entry and cell‐to‐cell transmission (2013) (69)
- The role of neutralizing antibodies in hepatitis C virus infection. (2012) (66)
- Semen characteristics in HIV-1 positive men and the effect of semen washing. (1997) (65)
- A Conserved Determinant in the V1 Loop of HIV-1 Modulates the V3 Loop To Prime Low CD4 Use and Macrophage Infection (2010) (62)
- Naturally Occurring Antibodies That Recognize Linear Epitopes in the Amino Terminus of the Hepatitis C Virus E2 Protein Confer Noninterfering, Additive Neutralization (2011) (61)
- Intercompartmental Recombination of HIV-1 Contributes to env Intrahost Diversity and Modulates Viral Tropism and Sensitivity to Entry Inhibitors (2011) (59)
- Genomic reconstruction of the SARS-CoV-2 epidemic in England (2021) (59)
- Hepatitis C Patient-Derived Glycoproteins Exhibit Marked Differences in Susceptibility to Serum Neutralizing Antibodies: Genetic Subtype Defines Antigenic but Not Neutralization Serotype (2011) (55)
- Role of SR-BI in HCV entry: kinetics and molecular 1 determinants 2 (2009) (55)
- Specific interaction of hepatitis C virus glycoproteins with mannan binding lectin inhibits virus entry (2010) (55)
- TT virus infection in patients with hepatitis C: frequency, persistence, and sequence heterogeneity. (1999) (55)
- A Diverse Panel of Hepatitis C Virus Glycoproteins for Use in Vaccine Research Reveals Extremes of Monoclonal Antibody Neutralization Resistance (2015) (54)
- Evolutionary trends of the first hypervariable region of the hepatitis C virus E2 protein in individuals with differing liver disease severity. (2002) (54)
- The Role of Humoral Innate Immunity in Hepatitis C Virus Infection (2012) (50)
- Students’ Views towards Sars-Cov-2 Mass Asymptomatic Testing, Social Distancing and Self-Isolation in a University Setting during the COVID-19 Pandemic: A Qualitative Study (2021) (48)
- Antigenicity and Immunogenicity of Differentially Glycosylated Hepatitis C Virus E2 Envelope Proteins Expressed in Mammalian and Insect Cells (2019) (45)
- Severe fibrosis in hepatitis C virus‐infected patients is associated with increased activity of the mannan‐binding lectin (MBL)/MBL‐associated serine protease 1 (MASP‐1) complex (2006) (44)
- Evolutionary dynamics of hepatitis C virus envelope genes during chronic infection. (2005) (43)
- Hepatitis C Virus Vaccine: Challenges and Prospects (2020) (40)
- All Surfaces Are Not Equal in Contact Transmission of SARS-CoV-2 (2020) (38)
- Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies (2021) (37)
- Discovery of Novel Alphacoronaviruses in European Rodents and Shrews (2016) (37)
- An ancestral host defence peptide within human β-defensin 3 recapitulates the antibacterial and antiviral activity of the full-length molecule (2015) (37)
- Immunogenicity of a new gorilla adenovirus vaccine candidate for COVID-19 (2020) (37)
- Two doses of the SARS-CoV-2 BNT162b2 vaccine enhance antibody responses to variants in individuals with prior SARS-CoV-2 infection (2021) (37)
- B-cell receptors expressed by lymphomas of hepatitis C virus (HCV)-infected patients rarely react with the viral proteins. (2014) (36)
- Hepatitis C Virus Envelope Glycoprotein Fitness Defines Virus Population Composition following Transmission to a New Host (2012) (35)
- Cloning, expression, and functional analysis of patient-derived hepatitis C virus glycoproteins. (2007) (34)
- HIV‐1 in semen: Determination of proviral and viral titres compared to blood, and quantification of semen leukocyte populations (1999) (34)
- Analysis of the binding of hepatitis C virus genotype 1a and 1b E2 glycoproteins to peripheral blood mononuclear cell subsets. (2005) (34)
- Concurrent evolution of regions of the envelope and polymerase genes of human immunodeficiency virus type 1 observed during zidovudine (AZT) therapy (1996) (33)
- Rapid roll out of SARS-CoV-2 antibody testing—a concern (2020) (33)
- Cross-genotype characterization of genetic diversity and molecular adaptation in hepatitis C virus envelope glycoprotein genes. (2007) (31)
- Novel functional hepatitis C virus glycoprotein isolates identified using an optimized viral pseudotype entry assay (2016) (30)
- Recombinant Human L-Ficolin Directly Neutralizes Hepatitis C Virus Entry (2014) (28)
- Fatal COVID-19 outcomes are associated with an antibody response targeting epitopes shared with endemic coronaviruses (2021) (27)
- Targeting a host-cell entry factor barricades antiviral-resistant HCV variants from on-therapy breakthrough in human-liver mice (2015) (27)
- Perceptions and Experiences of the University of Nottingham Pilot SARS-CoV-2 Asymptomatic Testing Service: A Mixed-Methods Study (2020) (26)
- Shared Common Ancestry of Rodent Alphacoronaviruses Sampled Globally (2019) (25)
- HIV coreceptor and chemokine ligand gene expression in the male urethra and female cervix (2005) (24)
- Therapeutic control of hepatitis C virus: the role of neutralizing monoclonal antibodies. (2008) (24)
- Cross-genotype AR3-specific neutralizing antibodies confer long-term protection in injecting drug users after HCV clearance. (2019) (23)
- Variation in the biological properties of HIV-1 R5 envelopes: implications of envelope structure, transmission and pathogenesis. (2010) (23)
- Concordance between semen‐derived HIV‐1 proviral DNA and viral RNA hypervariable region 3 (V3) envelope sequences in cases where semen populations are distinct from those present in blood (2002) (22)
- The Impact of Real-Time Whole-Genome Sequencing in Controlling Healthcare-Associated SARS-CoV-2 Outbreaks (2021) (22)
- Impacts of the COVID-19 Pandemic and Self-Isolation on Students and Staff in Higher Education: A Qualitative Study (2021) (21)
- Characterization of a novel monoclonal antibody targeting epitope II within hepatitis C virus E2 envelope glycoprotein (2017) (19)
- Dramatic Potentiation of the Antiviral Activity of HIV Antibodies by Cholesterol Conjugation* (2014) (19)
- Concurrent evolution of regions of the envelope and polymerase genes of human immunodeficiency virus type 1 during zidovudine (AZT) therapy. (1996) (18)
- In vitro evolution predicts emerging SARS-CoV-2 mutations with high affinity for ACE2 and cross-species binding (2021) (17)
- A case of hepatitis C virus transmission acquired through sharing a haemodialysis machine (2010) (16)
- A novel neutralizing human monoclonal antibody broadly abrogates hepatitis C virus infection in vitro and in vivo (2017) (15)
- Novel human anti-claudin 1 mAbs inhibit hepatitis C virus infection and may synergize with anti-SRB1 mAb. (2016) (15)
- Publisher Correction: SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway (2022) (15)
- Structure-Based Design of Hepatitis C Virus E2 Glycoprotein Improves Serum Binding and Cross-Neutralization (2020) (14)
- Standardized Method for the Study of Antibody Neutralization of HCV Pseudoparticles (HCVpp). (2018) (13)
- Flexible and rapid construction of viral chimeras applied to hepatitis C virus (2016) (13)
- Interferon‐Induced Transmembrane Proteins Mediate Viral Evasion in Acute and Chronic Hepatitis C Virus Infection (2019) (13)
- Development of a high-throughput pyrosequencing assay for monitoring temporal evolution and resistance associated variant emergence in the Hepatitis C virus protease coding-region. (2014) (12)
- A polymerase chain reaction method for the amplification of full-length envelope genes of HIV-1 from DNA samples containing single molecules of HIV-1 provirus. (2000) (12)
- Retrospective screening of routine respiratory samples revealed undetected community transmission and missed intervention opportunities for SARS-CoV-2 in the United Kingdom (2020) (12)
- Characterisation of a series of human immunodeficiency virus isolates derived sequentially from a single patient (1991) (12)
- Detection of HIV-1 by digoxigenin-labelled PCR and microtitre plate solution hybridisation assay and prevention of PCR carry-over by uracil-N-glycosylase. (1993) (12)
- Understanding and addressing vaccine hesitancy in the context of COVID-19: development of a digital intervention (2021) (12)
- GBV‐C/HGV coinfection in HIV‐1‐positive men: Frequent detection of viral RNA in blood plasma but absence from seminal fluid plasma (1998) (12)
- A Cost-Effectiveness Analysis of Shortened Direct-Acting Antiviral Treatment in Genotype 1 Noncirrhotic Treatment-Naive Patients With Chronic Hepatitis C Virus (2019) (11)
- Potent anti-SARS-CoV-2 Antibody Responses are Associated with Better Prognosis in Hospital Inpatient COVID-19 Disease (2020) (11)
- Poor reduction of HIV-1 RNA titres in nucleoside reverse transcriptase inhibitor experienced patients treated with indinavir combination therapy. (1999) (11)
- A next generation vaccine against human rabies based on a single dose of a chimpanzee adenovirus vector serotype C (2020) (11)
- Adjuvant formulated virus-like particles expressing native-like forms of the Lassa virus envelope surface glycoprotein are immunogenic and induce antibodies with broadly neutralizing activity (2020) (10)
- An Antigenically Diverse, Representative Panel of Envelope Glycoproteins for Hepatitis C Virus Vaccine Development (2021) (10)
- Non-ionic detergents facilitate non-specific binding of M13 bacteriophage to polystyrene surfaces. (2015) (9)
- Exploring the Psychological Impacts of COVID-19 Social Restrictions on International University Students: A Qualitative Study (2022) (9)
- Association of antibodies to hepatitis C virus glycoproteins 1 and 2 (anti‐E1E2) with HCV disease (2008) (8)
- Immunization with a synthetic consensus hepatitis C virus E2 glycoprotein ectodomain elicits virus‐neutralizing antibodies (2018) (8)
- Saliva for COVID-19 Testing: Simple but Useless or an Undervalued Resource? (2021) (8)
- Elevated serum activity of MBL and ficolin-2 as biomarkers for progression to hepatocellular carcinoma in chronic HCV infection. (2019) (8)
- Adjuvant formulated virus-like particles expressing native-like forms of the Lassa virus envelope surface glycoprotein are immunogenic and induce antibodies with broadly neutralizing activity (2020) (8)
- Pooled testing for SARS-CoV-2 could provide the solution to UK’s testing strategy (2020) (8)
- Production of single-stranded DNA using a uracil-N-glycosylase-mediated asymmetric polymerase chain reaction method. (1997) (7)
- Broad neutralization of hepatitis C virus‐resistant variants by Civacir hepatitis C immunoglobulin (2016) (7)
- Development and characterization of a human monoclonal antibody targeting the N-terminal region of hepatitis C virus envelope glycoprotein E1. (2018) (6)
- Retrieval of the Complete Coding Sequence of the UK-Endemic Tatenale Orthohantavirus Reveals Extensive Strain Variation and Supports Its Classification as a Novel Species (2019) (5)
- Genomic epidemiology of SARS-CoV-2 in a UK university identifies dynamics of transmission (2022) (5)
- Cholesterol conjugation potentiates the antiviral activity of an HIV immunoadhesin (2015) (5)
- Trichodysplasia Spinulosa Polyomavirus in Respiratory Tract of Immunocompromised Child (2018) (4)
- Discovery and Prevalence of Divergent RNA Viruses in European Field Voles and Rabbits (2019) (4)
- Antigenicity and Immunogenicity of Differentially Glycosylated HCV E2 Envelope Proteins Expressed in Mammalian and Insect Cells (2019) (4)
- Relationship Between Anxiety, Depression, and Susceptibility to Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Proof of Concept (2022) (4)
- Real-World Outcomes of Direct-Acting Antiviral Treatment and Retreatment in United Kingdom–Based Patients Infected With Hepatitis C Virus Genotypes/Subtypes Endemic in Africa (2021) (4)
- Hepatitis C virus quasispecies and pseudotype analysis from acute infection to chronicity in HIV-1 co-infected individuals. (2016) (4)
- The changing vaccine landscape: rates of COVID-19 vaccine acceptance and hesitancy in young adults during vaccine rollout. (2022) (4)
- Mixed-methods process evaluation of a residence-based SARS-CoV-2 testing participation pilot on a UK university campus during the COVID-19 pandemic (2021) (4)
- Viral genome wide association study identifies novel hepatitis C virus polymorphisms associated with sofosbuvir treatment failure (2020) (4)
- Precision community: a mixed methods study to identify determinants of adoption and implementation of targeted cancer therapy in community oncology (2020) (4)
- Analysis of Serine Codon Conservation Reveals Diverse Phenotypic Constraints on Hepatitis C Virus Glycoprotein Evolution (2013) (3)
- Expression of human ficolin-2 in hepatocytes confers resistance to infection by diverse hepatotropic viruses. (2019) (3)
- SARS-CoV-2 proteins (version 2020.2) in the IUPHAR/BPS Guide to Pharmacology Database (2020) (3)
- Discovery of Novel Coronaviruses in Rodents (2020) (3)
- Polymer microarrays rapidly identify competitive adsorbents of virus-like particles. (2020) (3)
- A bivalent HCV peptide vaccine elicits pan-genotypic neutralizing antibodies in mice. (2020) (3)
- Cloning and Analysis of Authentic Patient-Derived HCV E1/E2 Glycoproteins. (2018) (3)
- Coronavirus (CoV) proteins (version 2020.4) in the IUPHAR/BPS Guide to Pharmacology Database (2020) (3)
- Identification of Infectious Agents in High-Throughput Sequencing Data Sets Is Easily Achievable Using Free, Cloud-Based Bioinformatics Platforms (2019) (3)
- Use of short tandem repeat fingerprinting to validate sample origins in hepatitis C virus molecular epidemiology studies (2014) (3)
- Correction: A next generation vaccine against human rabies based on a single dose of a chimpanzee adenovirus vector serotype C (2021) (2)
- Simultaneous determination of HCV genotype and NS5B resistance associated substitutions using dried serum spots from São Paulo state, Brazil (2022) (2)
- A novel bivalent DNA vaccine encoding both spike protein receptor-binding domain and nucleocapsid protein of SARS-CoV-2 to elicit T cell and neutralising antibody responses that cross react with variants (2021) (2)
- Challenges on the development of a pseudotyping assay for Zika glycoproteins (2021) (2)
- Tagged polymerase chain reaction subtractive hybridization for the enrichment of phage display random peptide libraries. (2005) (1)
- Cost-Effectiveness Analysis of Baseline Testing for Resistance-Associated Polymorphisms to Optimize Treatment Outcome in Genotype 1 Noncirrhotic Treatment-Naïve Patients With Chronic Hepatitis C Virus (2018) (1)
- Optimization of the pseudoparticle system for standardized assessments of neutralizing antibodies against hepatitis C virus. (2022) (1)
- IFITMs mediate viral evasion in acute and chronic hepatitis C virus infection (2020) (1)
- Genomic epidemiology of SARS-CoV-2 in a university outbreak setting and implications for public health planning (2022) (1)
- A Qualitative Evaluation of the Barriers and Enablers for Implementation of an Asymptomatic SARS-CoV-2 Testing Service at the University of Nottingham: A Multi-Site Higher Education Setting in England (2022) (1)
- SARS-CoV-2 transmission from the healthcare setting into the home: a prospective longitudinal cohort study (2021) (1)
- Investigation of hospital discharge cases and SARS-CoV-2 introduction into Lothian care homes (2023) (1)
- Enterovirus D68 epidemic, UK, 2018, was caused by subclades B3 and D1, predominantly in children and adults, respectively, with both subclades exhibiting extensive genetic diversity (2021) (1)
- InFusion Cloning for the Generation of Biologically Relevant HCV Chimeric Molecular Clones. (2018) (1)
- Role of HVR1 sequence similarity in the cross-genotypic neutralization of HCV (2020) (1)
- Workforce Experiences of a Rapidly Established SARS-CoV-2 Asymptomatic Testing Service in a Higher Education Setting: A Qualitative Study (2022) (1)
- 1189 NEXT GENERATION SEQUENCING AND IN VITRO CHARACTERIZATION REVEAL POPULATION BOTTLENECKS AND FIXATION OF SELECTIVELY NEUTRAL MUTATIONS OCCURS POST-BI 201335 THERAPY (2013) (0)
- Virus E2 Protein Antibody Directed against the Hepatitis C and Neutralizing Human Monoclonal Identification of a Broadly Cross-Reacting (2013) (0)
- 1178 A NANOBODY RECOGNIZING A NOVEL EPITOPE IN HEPATITIS C VIRUS GLYCOPROTEIN E2 BROADLY NEUTRALIZES VIRUS ENTRY AND INHIBITS CELL–CELL TRANSMISSION (2013) (0)
- Publisher Correction: Genomic reconstruction of the SARS CoV-2 epidemic in England (2022) (0)
- Scavenger receptor class B type I genetic variants associated with disease severity in chronic hepatitis C virus infection (2022) (0)
- (2014) Use of short-tandem repeat (STR) fingerprinting to validate sample origins in hepatitis C virus molecular epidemiology studies. (2017) (0)
- Identification of New Functional Regions in Hepatitis C Virus Envelope Glycoprotein E2 (cid:1) (2011) (0)
- Development and characterization of a human monoclonal antibody for prevention of HCV recurrence in liver transplant patients (2017) (0)
- Coronavirus (CoV) proteins in GtoPdb v.2021.3 (2021) (0)
- The HCV Envelope Glycoprotein Down-Modulates NF-κB Signalling and Associates With Stimulation of the Host Endoplasmic Reticulum Stress Pathway (2022) (0)
- Prophylactic Treatment of COVID-19 in Care Homes Trial (PROTECT-CH) (2022) (0)
- Wombling surplus diagnostic nucleic acid for novel pathogenesis and genetic epidemiology of viral infections (2019) (0)
- Abstract A12: Analysis of advanced quantitative computed tomography imaging features in predicting the surgical resectability of advanced epithelial ovarian cancer (2020) (0)
- Human parainfluenza 2 & 4: Clinical and genetic epidemiology in the UK, 2013–2017, reveals distinct disease features and co‐circulating genomic subtypes (2022) (0)
- Role of HVR1 sequence similarity in the cross-genotypic neutralization of HCV (2020) (0)
- Wohlfahrtiimonas chitiniclastica Bacteremia in Hospitalized Homeless Man with Squamous Cell Carcinoma (2019) (0)
- Abstract 5677: Recurrent transcriptionally activeESR1fusions render therapeutic vulnerabilities to kinase inhibition in advanced breast cancer (2020) (0)
- P206 Hepatitis C Virus Compartmentalisation: Unravelling Genetic Complexity Within The Liver (2014) (0)
- University of Birmingham Structural flexibility of a conserved antigenic region in hepatitis C virus glycoprotein E2 recognized by broadly neutralizing antibodies (2015) (0)
- Hepatitis C subtyping assay failure in UK patients born in sub‐Saharan Africa: Implications for global treatment and elimination (2021) (0)
- Developing a pseudotype model to test infectivity among different Zika virus mutants (2019) (0)
- Semencharacteristics inHIV-1positive men and theeffect ofsemen washing (1997) (0)
- A multisite evaluation of antifungal use in critical care: implications for antifungal stewardship (2022) (0)
- Response to comments to “Open versus percutaneous tracheostomy in COVID-19: a multicentre comparison and recommendationfor future resource utilisation” (2021) (0)
- SARS-CoV-2 evolution during treatment of chronic infection (2021) (0)
- Evaluation of the relative potential for contact and doffing transmission of SARS-CoV-2 by a range of personal protective equipment materials (2022) (0)
- Author response: Interferon lambda 4 impacts the genetic diversity of hepatitis C virus (2019) (0)
- Developing a pseudotyping assay for Zika virus glycoprotein (2019) (0)
- Perceptions and Experiences of the University of Nottingham Pilot Asymptomatic Testing Service: A Mixed-Methods Study (2020) (0)
- Definition of a Conserved Immunodominant Domain on Hepatitis C Virus E2 Glycoprotein by Neutralizing Human Monoclonal Antibodies (cid:1) (2008) (0)
- Characterization of a novel human monoclonal antibody targeting the hepatitis C virus envelope protein (2016) (0)
- Discovery of novel highly divergent RNA viruses in European rodents and rabbits (2019) (0)
- Structure-based design of hepatitis C virus E2 glycoprotein (2020) (0)
- Investigation and genome characterisation of tatenale hantavirus in wild rodent populations in the United Kingdom (2019) (0)
- Urbanowicz, Richard A. and King, Barnabas and Ball, Jonathan K. and McClure, C. Patrick and Tarr, Alexander W. and Mason, Christopher P. (2016) Novel functional hepatitis C virus glycoprotein isolates identified using an optimised viral pseudotype entry (2017) (0)
- New Host Composition following Transmission to a Fitness Defines Virus Population Hepatitis C Virus Envelope Glycoprotein (2012) (0)
- Erratum to: 'Cross-genotype AR3-specific neutralizing antibodies confer long-term protection in injecting drug users after HCV clearance' (J Hepatol 2019; 71(1): 14-24). (2020) (0)
- A broadly neutralizing monoclonal antibody targeting hepatitis C virus prevents viral infection in vitro and in uPA/SCID mice with humanized liver (2015) (0)
- High-throughput sequencing of patients with symptoms of unknown etiology (2019) (0)
- Arbovirus circulation, epidemiology and spatiotemporal distribution in Uganda (2023) (0)
This paper list is powered by the following services:
Other Resources About Jonathan Ball
What Schools Are Affiliated With Jonathan Ball ?
Jonathan Ball is affiliated with the following schools:
